Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines

Once castration-resistant prostate cancer (CRPC) become resistant for cabazitaxel treatment, the patients are obliged to best supportive care. Therefore, the elucidation of the mechanism of the cabazitaxel-resistance and the conquest are important themes to improve the prognosis of the patients. The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Machioka, Kazuaki, Izumi, Kouji, Kadono, Yoshifumi, Iwamoto, Hiroaki, Naito, Renato, Makino, Tomoyuki, Kadomoto, Suguru, Natsagdorj, Ariunbold, Keller, Evan T., Zhang, Jian, Mizokami, Atsushi
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882326/
https://ncbi.nlm.nih.gov/pubmed/29662635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24609
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars